Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing
Status:
Completed
Trial end date:
2013-05-10
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to investigate the effect of romosozumab compared with
placebo on time to radiographic healing of fresh tibial diaphyseal fractures (fractures in
the midsection of the shinbone).